1-Bromo-2-(difluoromethyl)benzene (stabilised over Potassium Carbonate), 97.0%, 25g

4-bromo-5-chloro-6-methyl-2H-indazole, 97%, 5g

Ethyl 2-amino-2-(pyridin-2-yl)acetate dihydrochloride, 95.0%, 250mg

Methyl 5-morpholinopyrazine-2-carboxylate, 97%, 1g

6-Nitro-2-quinazolinamine, 98%, 250mg

2-Chloro-4-(trifluoromethoxy)aniline>97.0%(GC)(T)5g

ETHYL 2-AMINO-5-CHLORO-1H-INDOLE-3-CARBOXYLATE, 95.0%, 250mg

2,4-Difluoro-5-nitrophenol, 95.0%, 5g

4-Chloro-6-(methoxymethyl)-pyrimidine, 95.0%, 100mg

(R)-2-((R)-2-((tert-Butoxycarbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid, 97%, 1g

Hexahidroxoantimonato(V) de potasio, mínimo 98 %, 100 g, envase de plástico.

N-(tert-Butoxycarbonyl)-4-bromo-D-phenylalanine>98.0%(HPLC)1g

4-(4,4,5,5-Tetramethyl-1,3,2- dioxaborolan-2-yl)-1H-pyrazole, 98.0%, 25g